MSD - Bathi resik saben saham (EPS TTM) MRK

Simbol resmi perusahaan Merck (MRK)

The global manufacturing network of Merck & Co., Inc. (MRK) ensures a stable drug output, which is corroborated by the EPS trend over the last 12 months. Robert Davis's strategic deals support the capitalization despite regulatory pressure and the risk of Keytruda patent expirations. Meanwhile, the value of 0.99 reflects the metric's balance, linking the business's real yield with management's long-term goals and actual earnings per share.

MRK (Merck & Co., Inc.) riwayat Bathi resik saben saham sajrone patang kuartal pungkasan saka 04.07.2022 nganti 12.11.2026

Rincian analitis perusahaan Merck & Co., Inc.

- kuotasi saiki lan rata-rata prakiraan nilai:
Bagan rega Merck & Co., Inc.|MRK - Bagan rega target
- rincian nilai pasar emiten:
Kapitalisasi pasar Merck & Co.|MRK - Nilai Bisnis
- rincian valuasi buku bisnis:
Nilai Buku saben Saham Merck|MRK - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku merck.com|MRK - Total Aset Bisnis
- indikator beban utang lan likuiditas:
Total Utang marang Modal Merck & Co., Inc.|MRK - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Merck Sharp & Dohme|MRK - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Merck & Co.|MRK - Utang jangka dawa|Utang jangka cendhak perusahaan Merck|Rasio cepet merck.com
- indikator pendapatan resik lan kelipatan nilai:
MRK - Penghasilan resik|Bathi sing dikarepake Merck & Co., Inc.|MRK - Pangali P/E|Prakiraan rega marang bathi Merck|MRK - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Merck & Co.|MRK - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Merck|MRK - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan merck.com|MRK - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Merck & Co., Inc.
Analisis wiwitan perusahaan:Merck & Co., Inc. (MRK)
Produk sing diprodhuksi Merck Sharp & Dohme

This metric reflects the actual equity value of earnings, calculated as the ratio of net income to the number of shares outstanding over the past year. Analyzing the trailing 12-month net income per share allows for the removal of volatility and an assessment of Rob Davis's strategy to diversify the drug portfolio to neutralize patent risks for Merck & Co., Inc. (MRK).

Pesaing utama

LLY - Bathi saben saham sajrone rolas wulan pungkasan|ABBV: Bathi saben saham sajrone rolas wulan pungkasan|AZN: Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan NVS|NVO (Novo Nordisk Inc.) - Bathi resik saben saham (EPS TTM)|Amgen Inc (AMGN) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Pfizer Inc. (PFE)|sanofi.com - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) BMY (Bristol Myers Squibb)|Bathi resik saben saham sajroning taun lumaku GlaxoSmithKline plc|TAK - Bathi saben saham sajrone rolas wulan pungkasan|Teva Pharmaceutical Industries (TEVA) - Bathi resik saben saham sajrone 12 wulan pungkasan|RDY: Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan viatris.com (VTRS)|Bathi saben saham sajrone rolas wulan pungkasan Roivant Sciences|ZLAB: Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) BHC|Bathi resik saben saham sajrone 12 wulan pungkasan Cosmos Health Inc COSM